Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, announced the publication of a paper in the journal The Lancet Diabetes & Endocrinology that provides the ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an ...
The discovery, featured on the cover of Analytical Chemistry, could potentially slow the progression to full-blown diabetes.
As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare ...
Changes recommended in clinical trial design to include the voice of more people living with type 1 diabetes in evaluating therapy benefits Decades of research have demonstrated that beta cell ...
Daily Express US on MSN
Diabetes breakthrough as century-old medicine 'helps manage type 1 diabetes'
A clinical trial found that metformin, a drug typically used for type 2 diabetes, reduced insulin requirements by around 12% ...
Discovery featured on cover of Analytical Chemistry could potentially slow progression to full-blown diabetes.
NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Breakthrough T1D International, the leading global type 1 diabetes (T1D) research and advocacy organization, in partnership with Friends of Mewar and UNICEF ...
Youth Delegates Living with Type 1 Diabetes and Katie Bone, American Ninja Warrior Champion Who Lives with Type 1 Diabetes Provided Testimony at a Senate Appropriations Committee Hearing More than 1.5 ...
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has kicked off a series of Breakthrough T1D Walks ...
The leading research and advocacy organization for type 1 diabetes is holding its annual fundraiser at the McCormick Place ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback